跳转至内容
Merck
所有图片(1)

Key Documents

View All Documentation

IPVH09120

Millipore

Immobilon® -P PVDF Membrane

10 sheets, 9 cm x 12 cm, 0.45 µm pore size, transfer membrane

登录查看公司和协议定价
所有图片(1)

About This Item

分類程式碼代碼:
41105339
eCl@ss:
32031602
NACRES:
NB.22

product name

Immobilon®-P PVDF膜, 10 sheets, 9 cm x 12 cm, 0.45 µm pore size, Hydrophobic PVDF Transfer Membrane for western blotting.

材料

PVDF membrane
plain filter
white filter

品質等級

400

特點

hydrophobic

製造商／商標名

Immobilon®

技術

dot blot: suitable
western blot: suitable

過濾器長度 × 寬度

9 cm × 12 cm

孔徑

0.45 μm pore size

容量

160 μg/cm2 adsorption capacity (insulin)
 215 μg/cm2 adsorption capacity (BSA)
 294 μg/cm2 adsorption capacity (goat IgG)

相容性

for use with Amido black
for use with CPTS
for use with Colloidal gold
for use with Coomassie brilliant blue
for use with India ink
for use with Ponceau-S red
for use with Sypro<TMSYMBOL></TMSYMBOL> ruby
for use with Toluidine blue
for use with Transillumination

檢測方法

chemiluminescent
colorimetric
fluorometric
radioactive

運輸包裝

ambient

相关类别

一般說明

主要结合机制：静电，疏水
滤器编码：IPVH

應用

10片，9 cm x 12 cm，0.45 µm孔径，疏水性PVDF转移膜，用于蛋白印迹。

聯結

替代：INCP09120

法律資訊

Immobilon is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Yu Li et al.
Oncology letters, 19(1), 323-333 (2020-01-04)
Non-small cell lung cancer (NSCLC) has long been one of the most lethal types of cancer due to its lack of typical clinical symptoms at early stages and high risk of tumour recurrence, even following complete surgical resection. Multicourse chemotherapy
Saumya Bhagat et al.
Blood cells, molecules & diseases, 84, 102459-102459 (2020-06-20)
Sterile Inflammation (SI), a condition where damage associated molecular patterns (DAMPs) released from dying cells, leads to TLR (Toll-like receptor) activation and triggers hypoxemia in circulation leading to venous thrombosis (VT) through tissue factor (TF) activation, but its importance under
Julie Gavard et al.
Molecular and cellular biology, 29(9), 2469-2480 (2009-03-04)
Most proangiogenic polypeptide growth factors and chemokines enhance vascular permeability, including vascular endothelial growth factor (VEGF), the main target for anti-angiogenic-based therapies, and interleukin-8 (IL-8), a potent proinflammatory mediator. Here, we show that in endothelial cells IL-8 initiates a signaling

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门